PROMOTE: Prostate Cancer Medically Optimized Genome Enhanced Therapy Study

 

The Prostate Cancer Medically Optimized Genome Enhanced Therapy Study (PROMOTE) aims to individualize treatments for men with castration-resistant prostate cancer. DNA and tumor sequencing information of hundreds of men with advanced prostate cancer will be analyzed to help physicians and patients better understand which medication is right for them.